Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis
Document Type
Journal Article
Publication Date
6-14-2019
Journal
Molecular Therapy - Methods and Clinical Development
Volume
13
Inclusive Pages
484-492
DOI
10.1016/j.omtm.2019.04.009
APA Citation
Kusner, L. L., Yucius, K., Sengupta, M., Sprague, A., Desai, D., Nguyen, T. M., Charissé, K., Kuchimanchi, S. N., Kallanthottathil, R., Fitzgerald, k. J., Kaminski, H. J., & Borodovsky, A. (2019). Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis. Molecular Therapy - Methods and Clinical Development, 13 (). http://dx.doi.org/10.1016/j.omtm.2019.04.009
Peer Reviewed
1
Open Access
1